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ABSTRACT
Triple-Negative Basal-Like tumors, representing 15 to 20% of breast cancers, are 
very aggressive and with poor prognosis. Targeted therapies have been developed 
extensively in preclinical and clinical studies to open the way for new treatment 
strategies. The present study has focused on developing 3D cell cultures from 
SUM1315 and MDA-MB-231, two triple-negative basal-like (TNBL) breast cancer 
cell lines, using the liquid overlay technique. Extracellular matrix concentration, 
cell density, proliferation, cell viability, topology and ultrastructure parameters 
were determined. The results showed that for both cell lines, the best conditioning 
regimen for compact and homogeneous spheroid formation was to use 1000 cells per 
well and 2% Geltrex®. This conditioning regimen highlighted two 3D cell models: 
non-proliferative SUM1315 spheroids and proliferative MDA-MB-231 spheroids. In 
both cell lines, the comparison of 2D vs 3D cell culture viability in the presence of 
increasing concentrations of chemotherapeutic agents i.e. cisplatin, docetaxel and 
epirubicin, showed that spheroids were clearly less sensitive than monolayer cell 
cultures. Moreover, a proliferative or non-proliferative 3D cell line property would 
enable determination of cytotoxic and/or cytostatic drug activity. 3D cell culture 
could be an excellent tool in addition to the arsenal of techniques currently used in 
preclinical studies.
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INTRODUCTION
Triple-negative basal-like (TNBL) tumors comprise 
70% of the basal-like tumor subtype and 15% of all breast 
cancers. They are characterized by the non-expression of 
estrogen receptors (ER) and progesterone receptors (PR), 
and the absence of HER2 over-expression or ERBB-2 
amplification [1–4]. TNBL tumors mainly affect young 
women and are frequently associated with hereditary 
predispositions (BRCA1/2 germline mutations). This 
subtype has a very poor prognosis. TNBL tumours have 
a high proliferative capacity and may respond well 
to neoadjuvant chemotherapy or develop a resistance 
phenotype associated with metastases.
Conventional chemotherapy is based on different 
protocols such as FEC (5-fluorouracil, epirubicin, 
cyclophosphamide), FAC (5-fluorouracil, adriamycin, 
cyclophosphamide) or platinum salts (cisplatin), generally 
associated with side effects [5]. Otherwise, these tumors 
are not sensitive to classical breast targeted therapies since 
they do not express the relevant receptors (i.e. ER, PR and 
HER2). Thus, different groups have aimed to develop 
alternative targeted therapies. Targeting Epidermal Growth 
Factor Receptor 1 pathway with anti-EGFR Monoclonal 
antibodies (MoAb) or Tyrosine Kinase Inhibitors (TKI); 
or inhibiting the enzyme Poly-ADP-Ribose-Polymerase1 
(reparation of single-strand breaks)(PARPi) have shown 
promising activities in this preclinical and clinical setting) 
[5–8].
Monolayer in vitro cell culture studies represent a 
gold standard high throughput screening for toxicity of 
chemotherapeutics. However, this type of culture does not 
reproduce the three-dimensional (3D) structural properties 
of tumors. In fact, these tumors are biochemically and 
structurally characterized by (i) the generation of hypoxic 
regions, (ii) intercellular interactions, (iii) nutrient and 
growth factor exchanges, and (iv) the production of 
extracellular matrix that is essential to tumor stability and 
regulation of cellular functions [9–11].
Therefore, over recent decades, 3D cell culture, 
mimicking the 3D organization of in vivo-like tumors, 
has regained interest. This innovative technique consists 
in forming aggregated and compact cell clusters called 
spheroids. In this conformation, cells gain different 
characteristics depending on their position [9]. Variable 
gradients develop for oxygen, nutrients, lactate 
accumulation and pH [9]. The easily accessible peripheral 
cells are metabolically active and able to proliferate. 
Conversely, cells in the centre have unfavourable 
conditions and ultimately become quiescent and form a 
necrotic core [12, 13]. Taken together these metabolic 
and biochemical heterogeneous features reproduce the 
inconstancy of tumors with respect to their response 
to treatment and predict more accurately the features 
of in vivo tumors [14]. Several 3D culture methods are 
available based on (i) the induction of mechanical forces 
i.e. centrifugation pellet culture, spinner flask culture and 
rotary cell culture systems, (ii) micromolding in hydrogels 
and (iii) gravity i.e. hanging drop culture and liquid 
overlay culture [13, 15, 16]. Amongst these methods, the 
liquid overlay technique uses cells capacity to aggregate 
by gravity on non-adherent surfaces and form spheroids 
within a short period of time.
The 3D cell culture model is being increasingly 
integrated into the drug development process as it appears 
to be a more accurate model when studying the impact 
of chemotherapeutics [17]. In fact, in terms of predicting 
potential drug efficacy, it is currently better than 2D cell 
culture [9].
This work focuses on the development of a 3D cell 
culture from two TNBL breast cancer cell lines, SUM1315 
and MDA-MB-231, using the “liquid overlay” technique. 
For this, spheroid extracellular matrix concentration, cell 
density, metabolic activity, cell viability, proliferation, 
topology and ultrastructure parameters were firstly 
determined for both cell lines. Then, in order to better 
characterize 3D cell culture response, cell drugs sensibility 
of these spheroids was analysed in comparison to 2D cell 
culture.
RESULTS
3D cell culture development from TNBL cell 
lines
3D cell culture development was carried out using 
two TNBL cell lines, SUM1315 and MDA-MB-231. 
For each cell line, four parameters were determined: (i) 
extracellular matrix protein concentration (ii) cell spheroid 
concentration, (iii) spheroid cell metabolic activity and 
(iv) spheroid cell viability/mortality.
SUM1315 cell line
Extracellular matrix protein concentration
For these experiments, Geltrex® was used as 
extracellular matrix proteins. SUM1315 cells were 
seeded at 5000 cells per well in “Ultra-Low-Attachment” 
microplates (Corning®) at “Day 0”. Then, several 
conditioning regimens of Geltrex® were tested, i.e. just 
after cell seeding or 24h after cell seeding, and several 
Geltrex® concentrations (0.25 to 6%) were tested (Table 
1, Figure 1B, 1C) and compared with a control cell culture 
without Geltrex® (Figure 1A).
The results showed that when Geltrex® was added 
just after cell seeding (at Day 0), loose cell aggregates were 
detected in the presence of 0.25 and 0.5% of Geltrex® 
concentrations (Table 1, Figure 1A). In the presence of 1 
to 6% Geltrex®, only scattered spheroids were detected 
(Table 1, Figure 1B). When Geltrex® was added 24h after 
cell seeding (at Day 1), loose aggregates and scattered 
spheroids were observed in the presence of 0.25 to 0.5% 
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and 3 to 6% Geltrex® concentrations, respectively (Table 
1, Figure 1A, 1B). In contrast, single compact spheroids 
were detected with 1 to 2% Geltrex® added 24h after cell 
seeding (Table 1, Figure 1C). Therefore 2% Geltrex® 
added at Day 1 was the conditioning regimen chosen for 
3D culture development of the SUM1315 cell line.
Cell spheroid concentration determination
SUM1315 cell concentrations ranging from 50 
to 10000 cells per well were cultured in the presence of 
2% Geltrex® added after cell seeding at Day 1 (Figure 
2A). Spheroid diameters were monitored every day from 
Day 0 (control) to Day 14 with light microscopy, using 
ToupView® software. Results showed that for 50, 2000 
and 10000 cells per well, spheroid diameters were 299±54 
μm, 1198±45 μm and 2149±50 μm at Day 0 and decreased 
to 89±16 μm, 320±21 μm and 570±21 μm at Day 1, 
respectively. SUM1315 spheroid diameters and shapes 
remained constant until Day 14 for concentrations of 200 
to 2000 cells per well (313±14 μm for 2000 cells per well), 
and decreased for concentrations of 5000 and 10000 cells 
per well (401±31 μm for 10000 cells, p<0.00001) (Figure 
2A, 2B).
Metabolic activity study in 3D cell culture
Metabolic activity was measured by the colorimetric 
resazurin test involving the reduction of resazurin into 
resorufin. For the SUM1315 cell line, this parameter 
was analysed at Day 1, Day 8 and Day 14 in spheroids 
of 50 to 10000 cells per well. Optic density (OD) of 
resorufin increased significantly for concentrations of 
50, 200, 1000 and 2000 cells per well from Day 1 (with 
0.006±0.002, 0.007±0.003, 0.051±0.008 and 0.120±0.044, 
respectively) to Day 8 (with 0.084±0.021 (p<0.00001), 
0.076±0.022 (p<0.001), 0.179±0.015 (p<0.00001) and 
0.233±0.043 (p<0.01, respectively)) (Figure 2B–2C). For 
cell concentrations of 5000 and 10000 per well, the OD 
of resorufin remained stable after 8 days of culture, with 
OD of 0.255±0.025 and 0.306±0.027 at Day 1 compared 
to 0.275±0.024 (p=0.23) and 0.324±0.028 (p=0.73) at Day 
8, respectively.
After Day 8, the metabolic activity of SUM1315 
spheroids dropped dramatically for all cell concentrations 
to Day 14 (OD of 0.047±0.010 for 5000 cells per well) 
(Figure 2–2C).
Spheroid cell viability/mortality monitoring
SUM1315 spheroid cell viability was analyzed 
during the experiment (14 days) by fluorescence 
microscopy using Live/Dead® kit (Molecular Probes). 
Cells forming spheroids remained viable (green markings) 
with all studied concentrations (50 to 10000 cells per well) 
for the 14 days of culture (Figure 2D), with no change 
in green fluorescent probe intensity between Day 8 and 
Day 14.
All these results showed that whatever the tested cell 
concentrations in the presence of 2% Geltrex® added after 
aggregate formation, compact and homogenous spheroids 
were formed. Moreover, spheroid diameters and viability 
remained stable for 14 days with all cell concentrations. 
Nevertheless, metabolic activity in spheroids decreased 
dramatically for all cell concentrations after 8 days of 
culture.
MDA-MB-231 cell line
Extracellular matrix protein concentration
For 3D cell culture development with the MDA-
MB-231 cell line, the same Geltrex® concentrations 
and conditioning regimens were used as above. Single 
compact spheroids were detected with 2% Geltrex® added 
24h after cell seeding (data not shown).
Cell spheroid concentration determination
For this cell line, as previously, spheroid diameters 
obtained with MDA-MB-231 cell concentrations from 
50 to 10000 cells per well were measured every day 
from Day 0 to Day 14 with light microscopy using 
ToupView® Software (Figure 3A, 3B). At Day 0 for 
50, 2000 and 10000 cells per well, diameters were 
254±50 μm, 1203±100 μm and 2246±84 μm respectively. 
In contrast, spheroid diameters decreased significantly 
Table 1: Extracellular matrix concentration determination for spheroid formation with the SUM1315 cell line
Condition of Geltrex® adding
Percentage of Geltrex in the culture 
medium After cell seeding (Day 0)
24h after cell seeding once aggregate 
formation (Day 1)
0 (control) Unique loose aggregate Unique loose aggregate
0.25 - 0.5 Unique loose aggregate Unique loose aggregate
1 - 2 Scattered spheroids Unique compact spheroid
3 - 4 - 5 - 6 Scattered spheroids Scattered spheroids
Several Geltrex® concentrations from 0.25 to 6% were used. Two conditioning regimens of Geltrex® were tested: addition 
of Geltrex® (i) in the microplates just after cell seeding (corresponding to Day 0) and (ii) 24h after cell seeding and aggregate 
formation (corresponding to Day 1).
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Figure 1: Profile of spheroid formation with the SUM1315 cell line in light microscopy. Aggregates and spheroids were 
observed by light microscopy at Day 1, using ToupView® software. Spheroid formation was considered when cells were compacted in 
a unique and opaque to light aggregate. Magnification = 100X, scale bar = 200μm. (A) SUM1315 loose cell aggregates, (B) scattered 
spheroids, (C) single compact spheroid.
Figure 2: Parameter determination for SUM1315 cell line spheroid formation. For SUM1315 cell line spheroid formation, 50 to 
10000 cells were seeded in 96-wells microplates (“ULA” for Ultra Low Attachment, Corning®) at Day 0 and 2% Geltrex® was added to the 
wells at Day 1. All experiments were carried out at Day 1, Day 8 and Day 14. (A) Cell concentration determination for spheroid formation: 
the diameter of each spheroid was measured (μm) by light microscopy with ToupView® software. Day 0 measurements correspond to 
aggregate diameters. (B) Spheroid diameter evolution over time: spheroid diameter (μm) was measured with ToupView software® for all 
tested cell concentrations (log10 scale). (C) Cell metabolic activity in spheroids via resazurin test: the resazurin is reduced into resorufin 
by metabolically active cells. Corrected OD of resorufin (λ570- λ620 nm) was measured after 15h incubation with 60 μM resazurin in PBS. 
(D) Cell viability/mortality in spheroids with LiveDead® imaging: Green marking corresponds to calcein-AM penetration (viable cells). 
Red markings correspond to ethidium homodimer-1 cell penetration (dead cells). Scale bar = 200 μm. Graphs represent at least triplicate 
biological repeats and are displayed as mean ± SEM and *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 and *****p<0.00001.
Oncotarget5www.impactjournals.com/oncotarget
after adding Geltrex®. At Day 1, diameters were 134±23 
μm (p<0.00001), 612±59 μm (p<0.00001) and 826±90 
μm (p<0.00001) for 50, 2000 and 10000 cells per well, 
respectively. Furthermore, the monitoring of MDA-
MB-231 spheroids showed a significant increase in 
diameters at Day 8 for concentrations of 50 to 2000 cells 
per well with 317±65 μm (p<0.00001) and 843±69 μm 
(p<0.00001), respectively. Moreover, for concentrations 
of 5000 and 10000 cells per well, no diameter increase 
was detected under these experimental conditions (814±67 
μm for 10000 cells per well at Day 8, p=0.68 and 848±76 
μm at Day 14, p=0.27) (Figure 3A, 3B). After 14 days, 
spheroid diameters continued increasing significantly for 
cell concentrations of 50 to 1000 cells per well (608±148 
μm for 50 cells per well, p<0.00001).
Metabolic activity study in 3D cell culture
Metabolic activity assessment was carried out 
for 14 days, in MDA-MB-231 spheroids seeded with 
50 to 10000 cells per well (Figure 3C). The OD of 
resorufin significantly increased over time with all cell 
concentrations after 8 days of culture. At Day 1, OD was 
0.010±0.003, 0.062±0.005 and 0.165±0.023 and increased 
to 0.054±0.006 (p<0.00001), 0.115±0.010 (p<0.00001) 
and 0.244±0.035 (p<0.001) at Day 8 for 200, 1000 and 
10000 cells per well respectively.
The metabolic activity of spheroids continued 
increasing for spheroids of 50 to 200 cells per well 
(0.167±0.007 for 200 cells, p<0.00001), remained stable 
for spheroids of 1000 cells per well (0.128±0.014, p=0.11), 
and decreased significantly for spheroids of 2000, 5000 
and 10000 cells per well (0.074±0.037 for 10000 cells, 
p<0.00001 compared to Day 8).
Spheroid cell viability/mortality monitoring
MDA-MB-231 spheroid cell viability was monitored 
during the experiment (14 days) by fluorescence 
microscopy using Live/Dead® kit (Molecular Probes) 
(Figure 3D). Cells forming spheroids remained viable 
(green markings) with all studied concentrations (50 to 
10000 cells per well) for the 8 days of culture. In contrast, 
at day 14, green markings were less intense (in same 
conditions of exposure and gamma) with spheroids formed 
with 2000 to 5000 cells per well, and even absent with 
10000 cells per well.
Overall results obtained with the MDA-MB-231 
cell line also showed that whatever the tested cell 
concentrations in the presence of 2% Geltrex® added after 
aggregate formation, compact and homogenous spheroids 
were formed. Spheroid diameters increased clearly for 
concentrations of 50 to 2000 cells per well for 14 days, 
suggesting a proliferative property of the MDA-MB-231 
cell line under these experimental conditions. Moreover, 
metabolic activity in spheroids increased clearly during 
8 days of culture presenting stable viability for all cell 
concentrations. Nevertheless, for cell concentrations 
superior to 2000 per well, metabolic activity and viability 
(Live/Dead® kit) dropped after 14 days.
For further experiments, with both SUM1315 and 
MDA-MB-231 spheroid cell cultures, the conditioning 
regimen of 1000 cells per well and 2% Geltrex® were 
chosen.
Topological and ultrastructural 3D cell culture 
characterization
3D cell culture architecture of SUM1315 and MDA-
MB-231 spheroids with Scanning Electron Microscopy
Scanning Electron Microscopy (SEM) was used 
to assess the 3D structure of cells forming the spheroids. 
Both SUM1315 (Figure 4A, 4B, 4C) and MDA-MB-231 
(Figure 4D, 4E, 4F) compact and homogenous spheroids 
exhibited rounded shapes of about 300 μm with granular 
surfaces covered with stacked cells. These cells in clusters 
were 10 μm in diameter and most of them presented 
rounded morphology. They are all closely juxtaposed with 
extracellular matrix (ECM) filling the empty spaces.
Ultrastructure of SUM1315 and MDA-MB-231 
spheroids with Transmission Electron Microscopy
The organization and ultrastructure of cells forming 
the spheroids were analyzed using Transmission Electron 
Microscopy (TEM) of SUM1315 (Figure 5A, 5B, 5C, 5D) 
and MDA-MB-231 (Figure 5E, 5F, 5G, 5H) spheroids. 
SUM1315 (Figure 5A) and MDA-MB-231 spheroids 
(Figure 5E) displayed adjoined cells with intact plasma 
and nuclear membranes. Cells established contact by two 
types of cell junctions: tight junctions (Figure 5C, 5G) and 
anchoring junctions (zonula adherens, Figure 5D) as well 
as desmosomes (Figure 5B, 5H). Ultrastructural analysis at 
higher magnifications (M=15000 – 20000 X) revealed the 
presence of conventional organelles such as mitochondria, 
rough endoplasmic reticulum and lysosomes (Figure 5B, 5F).
2D and 3D TNBL cell culture metabolic activity 
comparison
The comparison of metabolic activity between 2D 
and 3D cell cultures (as described above) was analyzed 
with the resazurin test after 5 days of culture of SUM1315 
(Figure 6A) and MDA-MB-231 (Figure 6B) cell lines 
seeded at 1000 cells/well. SUM1315 cell metabolic 
activity in 2D cell culture was 0.098±0.005 AU and 
significantly higher than 3D cell culture with 0.053±0.008 
AU (p<0.00001) (Figure 6A). Similarly, for the MDA-
MB-231 cell line, it was 0.179±0.025 AU in 2D and 
significantly higher than 3D cell culture with 0.077±0.013 
AU (p<0.00001) (Figure 6B). These results showed that 
metabolic activity of cells cultured in 3D was lower than 
cells cultured in monolayer under these experimental 
conditions.
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Analysis of 2D and 3D TNBL cell culture 
sensitivity to drugs
Sensitivity of SUM1315 and MDA-MB-231 cell 
lines in 2D and 3D cell cultures (as described above) 
was studied in the presence of three conventional 
chemotherapeutic drugs i.e. cisplatin, docetaxel and 
epirubicin. A quantitative resazurin test was used after 5 
days of treatment to determine cell viability (Figures 7, 8, 
9). The percentage of cell viability was calculated by the 
ratio of the quantity of resorufin formed by treated cells 
in comparison with untreated cells. For 3D cell culture, 
spheroid diameter measurements and qualitative viability/
mortality analysis using the Live/Dead® kit were also 
performed at Day 5. In parallel, controls and solvent 
controls with DMSO 0.1% were also performed under the 
same culture conditions.
Sensitivity to cisplatin
For the SUM1315 cell line, analysis of the ratio of 
the quantity of resorufin formed in DMSO 0.1% treated 
cells in comparison with untreated control cells showed 
no impact of DMSO on cell viability, with 99±11% for 
2D cell culture (p=0.69) and 101±24% for 3D cell culture 
(p=0.61). With cisplatin, the analysis of cell viability 
in 3D and 2D cell cultures at day 5 was of 80±14% vs 
101±8% with 0.01 μM (p<0.00001), 72±9% vs 104±5% 
with 0.1 μM (p<0.00001), 74±9% vs 103±4% with 
Figure 3: Parameter determination for MDA-MB-231 cell line spheroid formation. For MDA-MB-231 cell line spheroid 
formation, 50 to 10000 cells were seeded in 96-wells microplates (“ULA” for Ultra Low Attachment, Corning®) at Day 0 and 2% Geltrex® 
was added to the wells at Day 1. All experiments were carried out at Day 1, Day 8 and Day 14. (A) Cell concentration determination 
for spheroid formation: the diameter of each spheroid was measured by light microscopy with ToupView® software. Day 0 measures 
correspond to aggregate diameters. (B) Spheroid diameter evolution over time: spheroid diameter (μm) was measured with ToupView 
software® for all tested cell concentrations (log10 scale). (C) Cell metabolic activity in spheroids via resazurin test: the resazurin is 
reduced into resorufin by metabolically active cells. Corrected OD of resorufin (λ570- λ620 nm) was measured after 15h incubation with 
60 μM resazurin in PBS. (D) Cell viability/mortality in spheroids with Live/Dead® imaging: Green marking corresponds to calcein-AM 
penetration (viable cells). Red markings correspond to ethidium homodimer-1 cell penetration (dead cells). Scale bar = 200 μm. Graphs 
represent at least triplicate biological repeats and are displayed as mean ± SEM and *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 and 
*****p<0.00001.
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1 μM (p<0.00001), and 66±4% vs 54±6% with 10 μM 
(p<0.00001), respectively (Figure 7Aa). These results 
showed a slight decrease in 3D SUM1315 cell viability 
whatever the cisplatin concentrations. In contrast, viability 
of 2D cell cultures decreased significantly only with a high 
cisplatin concentration (10 μM).
SUM1315 spheroid diameters were then measured 
with ToupView® software. The results showed similar 
diameters between 0.01 and 0.1 μM cisplatin treated 
spheroids (264±10 μm, p=0.14 and 264±12 μm, p=0.17, 
respectively) compared to controls (267±11 μm) after 5 
days of treatment (Figure 7Ab). Nevertheless, a decrease 
in spheroid diameters was detected after treatment with 1 
and 10 μM cisplatin (223±11 μm, p<0.00001 and 204±12 
μm, p<0.00001, respectively). Live/Dead® kit analysis of 
viability and mortality of 3D cell cultures showed similar 
cell viability of spheroids treated with 0.01 to 10 μM 
cisplatin to control spheroids (Figure 7Ac).
For the MDA-MB-231 cell line, analysis of the ratio 
of the quantity of resorufin formed in DMSO 0.1% treated 
Figure 4: 3D topology of SUM1315 and MDA-MB-231 spheroids by Scanning Electron Microscopy (SEM). Cells were 
seeded at 1000 cells per well with 2% Geltrex®, added at Day 1. SEM images were taken at Day 5 with Jeol 6060 LV scanning electron 
microscope. Scale bars are shown on all images. M=magnification SUM1315 spheroids: (A) M= 270X, (B) M=1500X, (C) M=2500X 
MDA-MB-231 spheroids at (D) M=200X, (E) M=1300X, (F) M=2000X. ECM= extracellular matrix, Black arrow= cell junction
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Figure 5: Ultrastructure of SUM1315 and MDA-MB-231 spheroids by Transmission Electron Microscopy (TEM). 
Cells were seeded at 1000 cells per well with 2% Geltrex®, added at Day 1. Images were taken after 5 days of culture with 
transmission electron microscope Hitachi H-7650. Scale bars are shown on all images. M=magnification SUM1315 cells ultrastructure 
in 3D cell culture conditions: (A) M=3000X, (B) M=15000X, (C) M=25000X, (D) M=25000X. MDA-MB-231 cells ultrastructure in 3D 
cell culture conditions: (E) M=3000X, (F) M=20000X, (G) M=60000X, (H) M=120000X. N=nucleus, Mit=mitochondria, Lys=lysosome, 
REG= Rough Endoplasmic Reticulum, ZA=zonula adherens. Scale bars are shown on all images.
Figure 6: Metabolic activity comparison of 2D vs 3D cell cultures with resazurin test. The resazurin is reduced into resorufin by 
metabolically active cells. The amount of resorufin formed thus reflects the metabolic activity of the cells. Corrected OD of resorufin (λ570- 
λ620 nm) was measured after 6h of incubation with resazurin in PBS (60 μM) in the presence of 1000 cells per well at seeding for both cell 
lines and both culture conditions. Measures were made for both cell lines (A) SUM1315 and (B) MDA-MB-231 and all conditioning regimens 
after one day of culture. Graphs represent at least triplicate biological repeats and are displayed as mean ± SEM, ***** = p<0.00001.
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Figure 7: 2D vs 3D cell culture sensitivity to cisplatin. (A) SUM1315 and (B) MDA-MB-231 cell line sensitivity to cisplatin 
(0.01, 0.1, 1, 10 μM) was assessed in 2D and 3D cell culture conditions after 5 days of treatment. (a) Cell viability in 2D and 3D culture 
conditions with the resazurin test: viability was calculated by the ratio of OD of resorufin formed in cisplatin-treated cells to 0.1% control 
DMSO cells. (b) Spheroid diameter measurement: this parameter was measured with ToupView® software (μm). (c) Live/Dead® spheroid 
imaging: Green marking corresponds to calcein-AM penetration (viable cells). Red markings correspond to ethidium homodimer-1 cell 
penetration (dead cells). Scale bar =200 μm. Results are displayed as mean ± SEM where *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
and *****p<0.00001.
Figure 8: 2D vs 3D cell culture sensitivity to docetaxel. (A) SUM1315 and (B) MDA-MB-231 cell lines sensibility to docetaxel 
(0.01, 0.1, 1, 10 μM) was assessed in 2D and 3D cell culture conditions after 5 days of treatment. (a) Cell viability in 2D and 3D culture 
conditions with the resazurin test: viability was calculated by the ratio of OD of resorufin on docetaxel-treated cells to 0.1% control 
DMSO cells. (b) Spheroid diameter measurement: this parameter was measured with ToupView® software (μm). (c) Live/Dead® spheroid 
imaging: Green marking corresponds to calcein-AM penetration (viable cells). Red markings correspond to ethidium homodimer-1 cell 
penetration (dead cells). Scale bar =200 μm. Results are displayed as mean ± SEM where *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
and *****p<0.00001.
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cells in comparison with untreated control cells showed 
no impact of DMSO at this concentration, with 98±5% 
for 2D (p=0.21) and 94±7% for 3D cell culture (p=0.16). 
With cisplatin, the analysis of 3D and 2D cell viability 
after treatment showed 97±8% vs 88±5% viability after 
0.01 μM cisplatin (p<0.01), 93±7% vs 91±15% for 0.1 
μM (p=0.68), 90±5% vs 89±16% for 1 μM (p=0.94) and 
86±4% vs 53±4% for 10 μM (p<0.00001), respectively 
(Figure 7Ba).
These results showed slight cisplatin toxicity with 
10 μM on MDA-MB-231 3D cell culture compared to 2D. 
Moreover, IC50 could not be determined for either cell culture.
MDA-MB-231 spheroid diameters analysis at Day 
5, in the presence of different concentrations of cisplatin 
showed similar diameters to controls after treatment with 
0.01 to 1 μM cisplatin. Nevertheless, a significant decrease 
in spheroid size with 10 μM (551±33 μm) compared to 
controls (680±39 μm, p<0.00001) (Figure 7Bb) was 
detected. In parallel, similar green markings were 
observed in spheroids treated with 0.01 to 1 μM cisplatin 
compared to controls, and lower viability was detected for 
spheroids treated with 10 μM (Figure 7Bc).
Sensitivity to docetaxel
For the SUM1315 cell line, the analysis of the ratio 
of the quantity of resorufin formed in DMSO 0.1% treated 
cells in comparison with untreated control cells showed no 
toxicity of DMSO at this concentration, with 102±% for 
2D (p=0.27) and 98±14% for 3D cell cultures (p=0.73).
SUM1315 cell line sensitivity to docetaxel was 
assessed under the same culture conditions (Figure 
8A). 3D and 2D cell culture viability was 89±9.0% vs 
58±4% with 0.01 μM docetaxel (p<0.00001), 92±8% vs 
49±3.0% for 0.1 μM (p<0. 00001), 95±15% vs 50±4% 
for 1 μM (p<0.00001) and 80±9.0% vs 50±4% for 10 μM 
(p<0.00001), respectively (Figure 8Aa). These results 
showed that sensitivity of the SUM1315 2D cell line to 
docetaxel remained relatively stable during the experiment 
in the presence of increasing concentrations of the drug, 
with the IC50 value never reached. The same results were 
observed for the SUM1315 3D cell line. Nevertheless, as 
with cisplatin, SUM1315 3D cell culture was less sensitive 
to docetaxel than the 2D cell culture (p<0.00001 for all 
tested concentrations).
SUM1315 spheroid diameters remained stable in 
the presence of increasing concentrations of docetaxel 
(175±11 μm, 182±16 μm, 171±8 μm, 167±19 μm for 
respectively 0.01, 0.1, 1, 10 μM docetaxel, compared to 
controls 182±1 μm (Figure 8Ab). Live/Dead® kit analysis 
of viability and mortality of 3D cell cultures showed 
similar cell viability of treated spheroids to controls for 
all docetaxel concentrations (Figure 8Ac). These results 
correlated with the high viability rates observed with the 
resazurin test for 3D cell culture.
Figure 9: 2D vs 3D cell culture sensitivity to epirubicin. (A) SUM1315 and (B) MDA-MB-231 cell line sensitivity to epirubicin 
(0.01, 0.1, 1, 10 μM) was assessed in 2D and 3D cell culture conditions after 5 days of treatment. (a) Cell viability in 2D and 3D culture 
conditions with the resazurin test: viability was calculated by the ratio of OD of resorufin in epirubicin-treated cells to 0.1% control 
DMSO cells. (b) Spheroid diameter measurement: this parameter was measured with ToupView® software (μm). (c) Live/Dead® spheroid 
imaging: Green marking corresponds to calcein-AM penetration (viable cells). Red markings correspond to ethidium homodimer-1 cell 
penetration (dead cells). Scale bar =200 μm. Results are displayed as mean ± SEM where *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
and *****p<0.00001.
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For the MDA-MB-231 cell line, the analysis of the 
ratio of the quantity of resorufin formed in DMSO 0.1% 
treated cells in comparison with untreated control cells 
showed no toxicity of DMSO at this concentration, with 
97±15% for 2D (p=0.65) and 98±19% for 3D cell culture 
(p=0.80).
With docetaxel, 3D vs 2D cell culture viability 
was 78±9% vs 94±17% for 0.01 μM (p<0.05), 70±17% 
vs 55±8% for 0.1 μM (p<0.05), 73±6% vs 33±5% for 
1 μM (p<0.00001), and 81±7% vs 27±8% for 10 μM 
(p<0.00001), respectively (Figure 8Ba). MDA-MB-231 
3D cell culture was again less sensitive than 2D cell 
culture with IC50 values of 0.2±0.004 μM for 2D and 
superior to 10 μM for 3D cell culture, and a ratio 3D/2D 
> 58 fold.
After docetaxel treatment, MDA-MB-231 spheroid 
diameters decreased significantly to a plateau with all 
tested concentrations (666±66 μm with 0.01 μM and 
609±64 μm with 10 μM) in comparison with controls 
(1002±144 μm, p<0.00001)(Figure 8Bb). Live/Dead® 
kit analysis showed that MDA-MB-231 spheroid 
viability remained stable in the presence of increasing 
concentrations of docetaxel (Figure 8Bc).
Sensitivity to epirubicin
SUM1315 3D and 2D cell culture viability after 
epirubicin treatment was 98±12% vs 76±3% for 0.01 μM 
(p<0.001), 85±15% vs 36±1% for 0.1 μM (p<0.00001), 
46±4% vs 22±1% for 1 μM (p<0.00001) and 46±4% vs 
24±5% for 10 μM (p<0.00001), respectively (Figure 9Aa). 
IC50 values of 2D and 3D cell culture were 0.1±0.004 
μM against 7.6±0.5 μM, respectively. These results 
showed that 3D cell culture was 140 fold less sensitive to 
epirubicin than 2D monolayer cell culture.
SUM1315 spheroid diameters remained stable 
in the presence of 0.01, 0.1 or 1 μM epirubicin (180±4 
μm, 181±5 μm and 178±6 μm, respectively) compared 
to controls (184±8 μm) (Figure 9Ab). However, spheroid 
diameters decreased significantly (47±8 μm, p<0.001) 
with 10 μM of the drug. Live/Dead® kit analysis 
confirmed that SUM1315 spheroids treated with 0.01 
and 0.1 μM showed the same viability as controls. In 
contrast, spheroids treated with 1 μM epirubicin presented 
a necrotic core (yellow markings), and were dead with 10 
μM (red markings) (Figure 9Ac).
For the MDA-MB-231 cell line, 3D and 2D cell 
culture viability was 94±11% vs 101±24% for 0.01 μM 
epirubicin (p=0.29), 86±8% vs 94±22% for 0.1 μM 
(p=0.19), 41±5% vs 36±7% for 1 μM (p<0.05) and 30±8% 
vs 15±1% for 10 μM (p<0.00001), respectively (Figure 
9Ba). IC50 values were 0.6±0.003 μM for 2D and 0.6±0.1 
μM for 3D cell culture. These results showed that MDA-
MB-231 3D cell culture was as sensitive to epirubicin as 
2D cell culture.
MDA-MB-231 spheroid diameters decreased 
significantly in a dose-dependent manner, in the presence of 
increasing concentrations of epirubicin: 986±155 μm (p<0.05), 
782±97 μm (p<0.00001) and 525±163 μm (p<0.00001) 
for 0.01, 0.1 and 1 μM epirubicin, respectively, against 
1096±157 μm for untreated spheroids (Figure 9Bb). With 
10 μM epirubicin, spheroids were destroyed. Live/Dead kit 
analysis of viability and mortality showed that for epirubicin 
concentrations of 0.01 to 1 μM, spheroid viability remained 
stable (Figure 9Bc). In contrast, remaining spheroids treated 
with 10 μM exhibited a predominance of diffuse red marked 
cells (Figure 9Bc).
DISCUSSION
To optimize in vitro assays for the evaluation of 
drug sensitivity in TNBL breast cancer cell lines, we 
have conducted different studies to develop optimal 
3D cell cultures from SUM1315 and MDA-MB-231 
cell lines, with the “liquid overlay” technique (“Ultra-
Low-Attachment” microplates, Corning®). Indeed, this 
technique presents several benefits, such as a single-per-
well spheroid formation, generated naturally by gravity. 
Futhermore, this method has been validated for a large 
number of cancer cell lines [18, 19]. The works allowed 
for determination of optimal culture conditions, metabolic 
activity, morphology and ultrastructure of cells within the 
spheroids. After model developing, the impact of several 
anticancer agents was studied on both 3D cell cultures in 
comparison to 2D cell cultures sensitivity.
For the development of 3D compact cell mass 
cultures with SUM1315 and MDA-MB-231 cell 
lines, the need for an extracellular matrix was first 
investigated. For this, Geltrex™ LDEV-Free (Reduced 
Growth Factor Basement Membrane Matrix, GIBCO®) 
was used as a specific mixture matrix as it contains 
mainly laminin, collagen IV, entactin and heparin 
sulfate proteoglycan. With both cell lines, the 2% 
Geltrex® concentration resulted in the formation of a 
single compact spheroid per well, with a 3.6±0.3 fold 
cell compaction for SUM1315 cell line and a 2.1±0.4 
fold compaction for the MDA-MB-231 cell line, 
whatever cell density. Indeed, some cell lines require 
specific components mimicking the extracellular matrix 
(ECM) such as laminin or collagen IV, in their culture 
medium. These components are responsible for the 
cell/extracellular matrix connections, and are able to 
generate an environment leading to the formation of 
intercellular connections [10, 15, 20]. Moreover, the 
Triple-Negative Basal-Like SUM1315 and MDA-
MB-231 cell lines express low protein intercellular 
junctions such as E-cadherin, which limit the ability of 
cells to organize themselves spontaneously into compact 
spheroids [19–22]. Similar Geltrex® concentrations and 
conditioning regimens were required to form spheroids 
with MDA-MB-231 in the literature [11, 15].
Cell density for compact and homogenous spheroid 
formation was then assessed with both cell lines under 
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the same experimental conditions as described above. 
Overall results showed different spheroid diameter 
evolutions according to TNBL cell line, under the same 
experimental conditions. Indeed, SUM1315 spheroids 
did not evolve over time in comparison to MDA-MB-231 
spheroids which had expanded. This could be explained 
by a proliferative capacity of the MDA-MB-231 cell line 
under these experimental conditions in comparison to the 
SUM1315 cell line that may exhibit a “stem-cell like” 
phenotype with slowed down proliferation rate [23]. In 
3D culture models, cells forming spheroids may or may 
not proliferate according to cell type and the extracellular 
matrix environment [24, 25]. Nevertheless, in both TNBL 
3D cell cultures, spheroid diameters did not exceed 
1000 μm, which could be explained by the fact that the 
spheroids had reached their growth plateau [19].
The metabolic activity of 3D-non-proliferative 
SUM1315 and 3D-proliferative MDA-MB-231 spheroids 
was then measured at day 1, day 8 and day 14 using the 
colorimetric resazurin test. This test is safe for cells, easily 
penetrates spheroids and has already been validated for a 
large number of 3D cell culture models [26, 27]. Overall 
results showed that SUM1315 spheroids exhibited 
metabolic activity only until 8 days of culture, whatever 
the cell density, whereas MDA-MB-231 spheroids 
exhibited metabolic activity until 14 days of culture with 
low cell concentrations. The decrease in metabolic activity 
and/or cell viability with LiveDead® Kit, detected in the 
presence of high cell concentrations and/or long-term 
incubation conditions, may be caused by the formation of 
necrotic or quiescent areas in spheroids, already described 
in other 3D models [19].
Optimal 3D cell culture conditions with both 
non-proliferative SUM1315 and proliferative MDA-
MB-231 cell lines required adding 2% Geltrex® after 
aggregate formation in “ULA microplates” (Corning®) 
in the presence of 1000 cells per well. This conditioning 
regimen of 3D culture was used to analyze the topology 
of spheroids with both cell lines by first Scanning 
Electron Microscopy (SEM). SEM observations showed 
the homogenous three-dimensional topology of these 
masses with tightly packed cells at the surface, covered 
with extracellular matrix. Then, Transmission Electron 
Microscopy (TEM) observations of “in-depth” spheroid 
profiles demonstrated that both cell lines resulted in the 
formation of compact and organized aggregates. Indeed, 
these spheroids exhibited round shapes with juxtaposed 
cells presenting intact membranes, intracellular organelles 
and intercellular junctions [27].
For 3D cell culture development, it was necessary 
to compare spheroids metabolic activity to 2D monolayer 
cultures. For both cell lines under the same experimental 
conditions, metabolic activity of 2D cell culture was 
significantly higher than that of 3D cell culture, probably 
due to cellular heterogeneity in spheroids also described 
in literature [14, 27]. Moreover, the comparison of 
metabolic activity between both cell lines in 2D or 3D cell 
cultures showed systematic lower activity of SUM1315 
than MDA-MB-231 cell line, probably correlated to their 
respective non-proliferative/proliferative profiles.
All these results showed the development of two 
TNBL 3D cell culture models using the “liquid overlay” 
technique that allowed the formation of single-per-well 
spheroids with quick and easy handling, presenting 
homogenous shapes with high reproducibility. These 
two 3D non-proliferative and proliferative models were 
then used to study anticancer agents effectiveness in 
comparison to 2D cell culture.
For these experiments, three drugs used in 
treatment protocols for BLTN breast cancers, alone 
or in combination, such as cisplatin, docetaxel and 
epirubicin were chosen [28]. Quantitative viability tests, 
spheroid diameter and Live/Dead® viability tests were 
performed. Overall results showed that with both non-
proliferative SUM1315 and proliferative MDA-MB-231 
TNBL cell lines, sensitivity profiles of 3D and 2D cell 
cultures seemed to be cell line- and drug-dependent. 
Indeed, cisplatin (platinum salt) is a cell cycle-dependent 
alkylating agent which creates inter and intrastrand DNA 
links, inducing serious DNA double-strand damage 
after the replication fork. Hence, this class of drug is 
promoted for BLTN tumors in combination with other 
chemotherapy agents [28]. Similarly, docetaxel is an 
antimitotic agent from the taxane family which stops 
cell mitosis division in proliferating tumoral cells. It has 
shown to be of interest for TNBL tumor treatment when 
used in combination with anti-angiogenic agents [28]. 
In our experimental conditions, cisplatin and docetaxel 
effectiveness analysis showed cytostatic activity only on 
proliferative MDA-MB-231 cell line whereas only a slight 
toxicity was detected on non-proliferative SUM1315 cell 
line model. These results suggest that proliferative-3D-
cell-culture models represent a great tool for antimitotic 
drugs evaluation.
Epirubicin is known to be more effective on triple-
negative breast tumors [28]. This drug is a very powerful 
non cell-cycle dependent DNA intercalating agent from 
the anthracycline family. With epirubicin, cytotoxicity 
tests profiles with both cell lines were different. Indeed, 
this drug showed a dose-dependent cytotoxic activity, 
whatever cell culture conditioning regimens. Nevertheless, 
3D cell culture remained less sensitive to epirubicin 
than 2D cell culture. These data suggest that the non-
proliferative and proliferative-3D-cell-culture models may 
be adapted to the evaluation of conventional cytotoxic 
drugs.
All these results demonstrated firstly a difference 
in response between 2D and 3D cell culture models for 
the two TNBL cell lines. Indeed, a systematic lowered 
sensitivity was detected for 3D cell culture compared 
to monolayer cell culture probably due to 3D cellular 
heterogeneity and/or resistance phenotypes. This 
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reproduces partly tumor response in vivo [27]. More, 
according to drug’s mechanism of action, i.e. cytotoxic or 
cytostatic, the choice of a proliferative or non-proliferative 
3D model seem to be decisive for drug efficacy’s 
prediction. These observations underline the added value 
of using 3D cell culture as a tool to explore sensitivity 
and resistance to chemotherapeutics, among the arsenal of 
models currently used in preclinical studies.
MATERIALS AND METHODS
2D cell culture
BLTN cell lines SUM1315 and MDA-MB-231 were 
obtained from Asterand. SUM1315 cells were seeded at 25 
000 cells per mL in 75 cm2 culture dish (Falcon®) at 37°C 
under 5% CO2, in 15 mL Ham’s F12 medium (Gibco®) 
supplemented with 5% decomplemented fetal calf 
serum, 10 mM HEPES* buffer, 20 mg/mL gentamycin, 
10 ng/mL EGF and 4 μg/mL of insulin, according to 
the supplier’s instructions [29, 30]. The MDA-MB-231 
cell line was seeded at 25 000 cells per mL in 75 cm2 
culture dish (Falcon ®) at 37°C under 5% CO2, in 15 
mL RPMI 1640 medium (Gibco®) supplemented with 
10% decomplemented fetal calf serum and 20 mg/mL 
gentamycin, according to the supplier’s instructions [29, 
30].
Cells having reached confluence were washed 
with Phosphate Buffer Saline (PBS, 1X, Sigma®) and 
trypsinized (Trypsin 1X, Sigma®) for 5 min at 37°C. Cells 
were taken up in 12 mL of culture medium and centrifuged 
for 10 minutes at 250 G. The pellet was taken up in 5 mL 
of culture medium and the number of cells per mL was 
determined by a cell count using a vital stain Trypan Blue. 
This allowed for counting the cell dilutions necessary for 
seeding cells in varying concentrations and defined for 
each experiment.
Liquid overlay 3D cell culture
Cells were seeded in “Ultra-Low-Attachment” round 
bottom microplates (Corning®) in order to prevent cellular 
adhesion to the support. After 24h of incubation, Geltrex® 
was deposited on aggregated cells, and microplates were 
agitated on a microplate shaker at 185 rpm for 20 min. 
Spheroid formation and diameter measurements were 
assessed with a light microscope (CFM-BDS-200 Realux 
Cofemo) associated with a camera (Industrial Digital 
Camera, UCMOS05100KPA) and ToupView® software.
Metabolism activity assessment using the 
resazurin test
The resazurin test is a colorimetric assay for 
cell viability that involves the reduction of resazurin to 
resorufin by the metabolically active mitochondria of 
cells. Resorufin is a fluorescent compound that exhibits 
a pink colouring. After a time of incubation, the amount 
of resorufin formed is directly proportional to the number 
of metabolically active cells. Cells cultured in 2D or 3D 
treated with the drugs for 5 days at 37°C were washed 
with PBS* and incubated with 60 μM of resazurin 
solubilized in PBS. Optical densities were measured at 
570 and 620 nm after 6 to 15 hours of incubation. The 
amount of reduced compound (resorufin) corresponding to 
the number of active cells per well was calculated for each 
condition. The survival rate was determined considering 
the ratio (OD
570-620nm
 treated well/OD
570-620nm
 untreated 
control) x 100. The half maximal inhibitory concentration 
(IC50) was calculated with the following formula: IC50 = 
EXP (LN (concentration > 50% inhibition) - ((signal > 
50% inhibition - 50) / (signal > 50% inhibition - signal 
< 50% inhibition) * LN (concentration >50% inhibition / 
concentration <50% inhibition))).
Imaging of 3D cell culture with the Live/Dead® 
kit
The Live/Dead® kit (Viability/Cytotoxicity kit, 
Molecular ProbesTM) is composed of two fluorochromes, 
the calcein-AM (green fluorescence) which is retained in 
viable cells and the ethidium homodimer-1 (ethD1, red 
fluorescence) which penetrates and binds to DNA of cells 
in phase of apoptosis or necrosis. The two probes were 
diluted in phosphate saline buffer to final concentrations 
of 4 mM for Calcein-AM and 2 mM for ethD-1. After 
several washings in Phosphate Buffer Saline (PBS), 
spheroids were incubated with 100 μL of the Calcein-
AM/EthD-1 solution for at least 45 min., protected from 
light. Observations were made with an epifluorescence 
microscope (Leica DMI 3000B, FITC canal) associated 
with CCD camera and Leica® Software.
Scanning electron microscopy
Scanning Electron Microscopy (SEM) assessed 
organization of cell components of the spheroids. 
Spheroids were washed with 0.2 M sodium cacodylate 
buffer pH 7.4 and fixed in 1.6% glutaraldehyde in 
cacodylate buffer overnight at 4°C. They were then rinsed 
in the same buffer and post-fixed for 1h with osmic acid 
in cacodylate buffer at ambient temperature. For spheroid 
visualization, a solution of 0.15% ruthenium red in water 
was added to the washes and fixative solutions. Fixed 
spheroids were then progressively dehydrated using a 
graded ethanol series (10 min. each in 25%, 50%, 70%, 
95%, 100% ethanol) and hexamethyldisilazane (3x10 
min.). After drying, the samples were mounted on stubs 
using adhesive carbon tabs and sputter-coated with gold-
palladium (JFC-1300, Jeol). Spheroids were observed with 
a scanning electron microscope Jeol 6060-LV at 5 kV in 
high-vacuum mode.
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Transmission electron microscopy
Transmission Electron Microscopy (TEM) achieved 
ultrastructural observations of spheroids. Spheroids were 
washed in 0.2M sodium cacodylate buffer (pH7.4), fixed 
in 1.6% glutaraldehyde for 24 hours at 4°C. Specimens 
were then washed three times (10 min.) in Na cacodylate 
buffer, post fixed 1h with 1% osmium tetroxide in 
Na cacodylate buffer and washed three times in Na 
cacodylate buffer. In order to visualize the spheroids, a 
solution of 0.15% ruthenium red in water was added to 
the buffer and fixative solutions. Fixed spheroids were 
then progressively dehydrated in ethanol (70%, 95%, 
100%) and acetone. Subsequently, they were infiltrated 
with acetone and EPON resin mixture (2:1, 1:1, 1:2 for 
1h). Specimens were embedded in resin EPON overnight 
at room temperature, and cured 2 days at 60°C. Thin 
sections (70 nm) were cut using a UC6 ultramicrotome 
(Leica) and stained with uranyl acetate and Pb citrate. 
Carbon was evaporated using CE6500 unit. Observation 
of the ultrastructural organization of cells within the 
spheroids was then conducted with a transmission electron 
microscope (Hitachi H-7650) at 80 kV acceleration 
voltage. Micrographs were made using a Hamamatsu 
AMT camera placed in a side position.
Drug solubilization and cell exposure
Docetaxel, cisplatin and epirubicin were prepared at a 
stock solution of 10 mM. Cisplatin and docetaxel were not 
soluble in water. These were solubilized in dimethylsulfoxide 
(DMSO) and the final concentration in each cell culture well 
was always of 0.1%. Epirubicin was solubilized in distilled 
water. For all drug treatment experiments, cells cultured in 
2D and 3D condition were seeded at a concentration of 1000 
cells per well for both cell lines. Cells were then exposed 
to the drugs 24h after seeding for 2D cell culture (phase of 
exponential growth) and 24h after Geltrex® adding for 3D 
cell culture. After five days of incubation, cell viability was 
then assessed for each condition with the resazurin test. For 
3D cell culture, spheroid diameter measurements and Live/
Dead® viability/mortality tests were also performed at the 
end of each treatment.
Statistical analysis
Results were expressed as means ± standard deviation 
of n independent experiments. All experiments were 
performed at least in triplicate and then statistically compared 
using a Student’s t-test. Tests were two-sided and the nominal 
level of significance was p<0.05 (*), p<0.01 (**), p<0.001 
(***), p<0.0001 (****) and p<0,00001 (*****).
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